Harro J - Search Results

1

Effects of serotonin transporter promoter and BDNF Val66Met genotype on personality traits in a population representative sample of adolescents.

Hiio K, Merenäkk L, Nordquist N, Parik J, Oreland L, Veidebaum T, Harro J. Hiio K, et al. Among authors: harro j. Psychiatr Genet. 2011 Oct;21(5):261-4. doi: 10.1097/YPG.0b013e32834371e8. Psychiatr Genet. 2011. PMID: 21206400

2

Age-related differences of cholecystokinin receptor binding in the rat brain.

Harro J, Oreland L. Harro J, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1992 May;16(3):369-75. doi: 10.1016/0278-5846(92)90088-v. Prog Neuropsychopharmacol Biol Psychiatry. 1992. PMID: 1317043

3

Cholecystokinin receptors and animal models of anxiety.

Harro J, Oreland L, Vasar E. Harro J, et al. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:479A-480A. doi: 10.1097/00002826-199201001-00250. Clin Neuropharmacol. 1992. PMID: 1498919 No abstract available.

4

Role of N-methyl-D-aspartic acid and cholecystokinin receptors in apomorphine-induced aggressive behaviour in rats.

Lang A, Harro J, Soosaar A, Kõks S, Volke V, Oreland L, Bourin M, Vasar E, Bradwejn J, Männistö PT. Lang A, et al. Among authors: harro j. Naunyn Schmiedebergs Arch Pharmacol. 1995 Apr;351(4):363-70. doi: 10.1007/BF00169076. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 7630427

5

Social isolation of rats increases the density of cholecystokinin receptors in the frontal cortex and abolishes the anti-exploratory effect of caerulein.

Vasar E, Peuranen E, Harro J, Lang A, Oreland L, Männistö PT. Vasar E, et al. Among authors: harro j. Naunyn Schmiedebergs Arch Pharmacol. 1993 Jul;348(1):96-101. doi: 10.1007/BF00168543. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 8397343

6

Cholecystokinin receptors and memory: a radial maze study.

Harro J, Oreland L. Harro J, et al. Pharmacol Biochem Behav. 1993 Mar;44(3):509-17. doi: 10.1016/0091-3057(93)90160-u. Pharmacol Biochem Behav. 1993. PMID: 8451255

7

Depression as a spreading neuronal adjustment disorder.

Harro J, Oreland L. Harro J, et al. Eur Neuropsychopharmacol. 1996 Aug;6(3):207-23. doi: 10.1016/0924-977x(96)00022-3. Eur Neuropsychopharmacol. 1996. PMID: 8880081 Review.

8

Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation.

Harro J, Oreland L, Vasar E, Bradwejn J. Harro J, et al. Eur Neuropsychopharmacol. 1995 Dec;5(4):447-55. doi: 10.1016/0924-977x(95)00015-h. Eur Neuropsychopharmacol. 1995. PMID: 8998396

9

Different molecular forms of cholecystokinin and CCKB receptor binding in the rat brain after chronic antidepressant treatment.

Harro J, Löfberg C, Pähkla R, Matto V, Rägo L, Oreland L, Allikmets L. Harro J, et al. Naunyn Schmiedebergs Arch Pharmacol. 1997 Jan;355(1):57-63. doi: 10.1007/pl00004918. Naunyn Schmiedebergs Arch Pharmacol. 1997. PMID: 9007843

10

Role of fluidity of membranes on the guanyl nucleotide-dependent binding of cholecystokinin-8S to rat brain cortical membranes.

Rinken A, Harro J, Engström L, Oreland L. Rinken A, et al. Among authors: harro j. Biochem Pharmacol. 1998 Feb 15;55(4):423-31. doi: 10.1016/s0006-2952(97)00479-6. Biochem Pharmacol. 1998. PMID: 9514076

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters